Oakworth Capital’s Organon & Co OGN Stock Holding History

Oakworth Capital’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$149	Hold	11	–	–	﹤0.01%	924
2026 Q1	$66	Hold	11	–	–	﹤0.01%	846
2025 Q4	$79	Hold	11	–	–	﹤0.01%	852
2025 Q3	$117	Hold	11	–	–	﹤0.01%	830
2025 Q2	$106	Hold	11	–	–	﹤0.01%	627
2025 Q1	$164	Sell	11 -14	-56%	-$215	﹤0.01%	680
2024 Q4	$373	Sell	25 -186	-88%	-$3.03K	﹤0.01%	616
2024 Q3	$4.04K	Hold	211	–	–	﹤0.01%	578
2024 Q2	$4.37K	Hold	211	–	–	﹤0.01%	585
2024 Q1	$3.97K	Sell	211 -7	-3%	-$120	﹤0.01%	564
2023 Q4	$3.14K	Hold	218	–	–	﹤0.01%	589
2023 Q3	$3.78K	Sell	218 -77	-26%	-$1.61K	﹤0.01%	521
2023 Q2	$6.14K	Sell	295 -4	-1%	-$87	﹤0.01%	520
2023 Q1	$7.03K	Hold	299	–	–	﹤0.01%	473
2022 Q4	$8.35K	Hold	299	–	–	﹤0.01%	438
2022 Q3	$8K	Hold	299	–	–	﹤0.01%	472
2022 Q2	$10K	Buy	+299	New	+$10.5K	﹤0.01%	446
2022 Q1	–	Sell	-332	Closed	-$9K	–	575
2021 Q4	$9K	Buy	332 +10	+3%	+$326	﹤0.01%	491
2021 Q3	$10K	Sell	322 -1,697	-84%	-$54.3K	﹤0.01%	471
2021 Q2	$61K	Buy	+2,019	New	+$66.5K	0.01%	290

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Oakworth Capital's OGN Position: Q2 2026 in Review

Oakworth Capital held its Organon & Co (OGN) position steady in Q2 2026 at 11 shares worth $149. The position accounts for ﹤0.01% of the portfolio, ranked #924.

Oakworth Capital first reported a position in OGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $61K in Q2 2021. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

Oakworth Capital held 11 shares of Organon & Co worth $149 as of Q2 2026.
Oakworth Capital left its Organon & Co share count unchanged in Q2 2026.
Organon & Co made up ﹤0.01% of Oakworth Capital's portfolio in Q2 2026, its #924 holding.
Oakworth Capital first reported a position in Organon & Co in Q2 2021 and has held it in 20 quarters since.
Oakworth Capital's Organon & Co position peaked at $61K in Q2 2021.
631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Oakworth Capital's 13F filing for Q2 2026, filed 22 Jul 2026.